SRNE logo

Sorrento Therapeutics (SRNE) Total Expenses

Annual Total Expenses

$441.34 M
+$20.39 M+4.84%

December 31, 2022

Summary

Performance

1-Year Change

+4.84%

3-Year Change

+94.75%

5-Year Change

+339.5%

15-Year Change

+339.5%

SRNE Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.55%
SRNE annual total expenses is higher than 77.55% of companies in Healthcare sector

High & Low

All-time High

$441.34 M
SRNE annual total expenses is currently at an all-time high

3-Year Low

$420.95 M
SRNE annual total expenses is currently +4.84% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
SRNE previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
SRNE next annual earnings announcement has not yet been scheduled

OtherSRNEexpensesmetrics:

Annual Interest Expense

$8.57 M
SRNE annual interest expense is $8.57 million

Annual Income Tax

-$2.42 M
SRNE annual income tax is -$2.42 million

Annual Operating Expenses

$407.89 M
SRNE annual total operating expenses is $407.89 million

Annual Cost Of Goods Sold

$33.45 M
SRNE annual cost of goods sold is $33.45 million

Quarterly Total Expenses

$91.79 M
-$13.31 M-12.66%

June 30, 2023

Summary

Performance

3-Month Change

-12.66%

1-Year Change

-12.66%

3-Year Change

-12.66%

5-Year Change

-12.66%

SRNE Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.57%
SRNE quarterly total expenses is higher than 74.57% of companies in Healthcare sector

High & Low

All-time High

$127.54 M
SRNE quarterly total expenses is currently -28.03% below its historical high of $127.54 million

3-Year Low

$91.79 M
SRNE quarterly total expenses is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
SRNE previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
SRNE next earnings announcement has not yet been scheduled

OtherSRNEexpensesmetrics:

Quarterly Interest Expense

$2.67 M
SRNE quarterly interest expense is $2.67 million

Quarterly Income Tax

$671.00 K
SRNE quarterly income tax is $671.00 thousand

Quarterly Operating Expenses

$83.34 M
SRNE quarterly total operating expenses is $83.34 million

Quarterly Cost Of Goods Sold

$8.45 M
SRNE quarterly cost of goods sold is $8.45 million

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

Annual Total Expenses

$441.34 M
SRNE annual total expenses is $441.34 million

Annual Cost Of Goods Sold

$33.45 M
SRNE annual cost of goods sold is $33.45 million

Annual Operating Expenses

$407.89 M
SRNE annual total operating expenses is $407.89 million

SRNE Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.8%-12.7%
3 y3 years+94.8%-12.7%
5 y5 years+339.5%-12.7%

SRNE Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+4.8%-28.0%at low
5 y5-yearat high+94.8%-28.0%+80.4%
alltimeall timeat high>+9999.0%-28.0%>+9999.0%

Sorrento Therapeutics Total Expenses History

DateAnnualQuarterly
Jun 2023
-
$91.79 M(-12.7%)
Mar 2023
-
$105.10 M(+10.2%)
Dec 2022
$441.34 M(+4.8%)
$95.36 M(-25.2%)
Sep 2022
-
$127.54 M(+23.4%)
Jun 2022
-
$103.34 M(-10.2%)
Mar 2022
-
$115.10 M(-2.5%)
Dec 2021
$420.95 M(+74.3%)
$117.99 M(+15.3%)
Sep 2021
-
$102.32 M(-6.1%)
Jun 2021
-
$108.99 M(+18.9%)
Mar 2021
-
$91.65 M(+16.3%)
Dec 2020
$241.51 M(+6.6%)
$78.80 M(+31.4%)
Sep 2020
-
$59.97 M(+15.7%)
Jun 2020
-
$51.85 M(+1.9%)
Mar 2020
-
$50.88 M(-10.3%)
Dec 2019
$226.61 M(+50.4%)
$56.70 M(-4.0%)
Sep 2019
-
$59.06 M(+3.9%)
Jun 2019
-
$56.84 M(+5.2%)
Mar 2019
-
$54.01 M(+6.4%)
Dec 2018
$150.67 M(+50.0%)
$50.76 M(+19.4%)
Sep 2018
-
$42.50 M(+37.8%)
Jun 2018
-
$30.85 M(+16.1%)
Mar 2018
-
$26.57 M(+22.7%)
Dec 2017
$100.42 M(+47.6%)
$21.64 M(-24.2%)
Sep 2017
-
$28.56 M(+31.3%)
Jun 2017
-
$21.75 M(-23.6%)
Mar 2017
-
$28.46 M(+19.8%)
Dec 2016
$68.05 M(+24.7%)
$23.76 M(+46.9%)
Sep 2016
-
$16.18 M(+5.3%)
Jun 2016
-
$15.37 M(+20.6%)
Mar 2016
-
$12.74 M(-33.1%)
Dec 2015
$54.58 M
$19.05 M(+50.4%)
Sep 2015
-
$12.67 M(+8.2%)
Jun 2015
-
$11.71 M(+4.9%)
DateAnnualQuarterly
Mar 2015
-
$11.15 M(+5.8%)
Dec 2014
$38.36 M(+137.6%)
$10.54 M(+25.4%)
Sep 2014
-
$8.41 M(-4.1%)
Jun 2014
-
$8.77 M(-17.6%)
Mar 2014
-
$10.64 M(+64.8%)
Dec 2013
$16.14 M(+196.9%)
$6.46 M(+90.4%)
Sep 2013
-
$3.39 M(-7.1%)
Jun 2013
-
$3.65 M(+37.8%)
Mar 2013
-
$2.65 M(+41.0%)
Dec 2012
$5.44 M(+44.1%)
$1.88 M(+36.3%)
Sep 2012
-
$1.38 M(+18.6%)
Jun 2012
-
$1.16 M(+14.2%)
Mar 2012
-
$1.02 M(+14.2%)
Dec 2011
$3.77 M(+51.2%)
$891.20 K(+12.0%)
Sep 2011
-
$795.40 K(-31.6%)
Jun 2011
-
$1.16 M(+26.3%)
Mar 2011
-
$921.40 K(+31.5%)
Dec 2010
$2.49 M(+161.5%)
$700.50 K(+25.1%)
Sep 2010
-
$559.90 K(-11.5%)
Jun 2010
-
$633.00 K(+5.3%)
Mar 2010
-
$601.40 K(-12.8%)
Dec 2009
$954.10 K(+3612.5%)
$689.90 K(+189.0%)
Sep 2009
-
$238.70 K(+832.4%)
Jun 2009
-
$25.60 K(-121.6%)
Dec 2008
$25.70 K(-89.3%)
-$118.70 K(-194.4%)
Sep 2008
-
$125.80 K(+2229.6%)
Jun 2008
-
$5400.00(-59.1%)
Mar 2008
-
$13.20 K(+78.4%)
Dec 2007
$240.60 K(-45.2%)
$7400.00(-30.2%)
Sep 2007
-
$10.60 K(-15.9%)
Jun 2007
-
$12.60 K(-94.0%)
Mar 2007
-
$209.90 K
Dec 2006
$439.30 K
-

FAQ

  • What is Sorrento Therapeutics annual total expenses?
  • What is the all time high annual total expenses for Sorrento Therapeutics?
  • What is Sorrento Therapeutics annual total expenses year-on-year change?
  • What is Sorrento Therapeutics quarterly total expenses?
  • What is the all time high quarterly total expenses for Sorrento Therapeutics?
  • What is Sorrento Therapeutics quarterly total expenses year-on-year change?

What is Sorrento Therapeutics annual total expenses?

The current annual total expenses of SRNE is $441.34 M

What is the all time high annual total expenses for Sorrento Therapeutics?

Sorrento Therapeutics all-time high annual total expenses is $441.34 M

What is Sorrento Therapeutics annual total expenses year-on-year change?

Over the past year, SRNE annual total expenses has changed by +$20.39 M (+4.84%)

What is Sorrento Therapeutics quarterly total expenses?

The current quarterly total expenses of SRNE is $91.79 M

What is the all time high quarterly total expenses for Sorrento Therapeutics?

Sorrento Therapeutics all-time high quarterly total expenses is $127.54 M

What is Sorrento Therapeutics quarterly total expenses year-on-year change?

Over the past year, SRNE quarterly total expenses has changed by -$13.31 M (-12.66%)